Campus News

Liver Researcher Named Keystone Fellow

Liver Researcher Named Keystone Fellow

Esperanza Arias-Perez, Pharm.D., Ph.D., assistant professor of medicine and of pathology at Einstein, has been named a 2023 Keystone Symposia Fellow. She is one of only 10 investigators nationwide selected for the honor, which recognizes rising talent in biological and biomedical research. 

The competitive one-year program is designed to provide early-career researchers from underrepresented and other disadvantaged backgrounds with the skills they need to successfully pursue leadership and decision-making roles in academic, industry, and government research sectors.

Dr. Arias-Perez, who is a member of the Marion Bessin Liver Research Center at Einstein, Einstein’s Institute for Aging Research, and Montefiore Einstein Cancer Center, focuses on liver-related disease, ranging from nonalcoholic steatohepatitis to liver cancer, with a special interest in the molecular basis underlying clinical disparities. 

Dr. Arias-Perez received her Ph.D. from the School of Medicine at the Autonomous University of Madrid (Spain) and has worked in clinical research at Ferring Pharmaceuticals and at Pfizer. As a Fulbright postdoctoral fellow in the lab of Ana Maria Cuervo, M.D., Ph.D., professor of developmental and molecular biology and of medicine at Einstein, Dr. Arias-Perez studied mammalian autophagy in the context of aging and age-related diseases.

More From Einstein

Preparing New Grads for Hospital Roles
Einstein Celebrates 65th Commencement
Class of 2027 Receives White Coats
Mentoring in Medicine Paves Way for Success
Biomedical Sciences Leadership Program Begins
Einstein, Lehman Launch M.S. Program
2023 National Diversity Award
Health Equity Scholarship Honors Nilda Soto
Longevity Gene Project Awarded $13.6M


Campus News
Research Notes
Motivations: Donors & Alumni
More From This Issue

Past Issues

Download Magazine



  • This field is for validation purposes and should be left unchanged.